FRACTYL HEALTH INC (GUTS) Fundamental Analysis & Valuation

NASDAQ:GUTS • US35168W1036

Current stock price

0.4732 USD
-0.03 (-5.36%)
At close:
0.4703 USD
0 (-0.61%)
After Hours:

This GUTS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. GUTS Profitability Analysis

1.1 Basic Checks

  • GUTS had negative earnings in the past year.
  • In the past year GUTS has reported a negative cash flow from operations.
  • In the past 5 years GUTS always reported negative net income.
  • GUTS had a negative operating cash flow in each of the past 5 years.
GUTS Yearly Net Income VS EBIT VS OCF VS FCFGUTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • GUTS has a Return On Assets of -106.94%. This is amonst the worse of the industry: GUTS underperforms 81.48% of its industry peers.
Industry RankSector Rank
ROA -106.94%
ROE N/A
ROIC N/A
ROA(3y)-97.75%
ROA(5y)-92.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GUTS Yearly ROA, ROE, ROICGUTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

  • Looking at the Gross Margin, with a value of 100.00%, GUTS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • GUTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GUTS Yearly Profit, Operating, Gross MarginsGUTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. GUTS Health Analysis

2.1 Basic Checks

  • GUTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for GUTS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GUTS Yearly Shares OutstandingGUTS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
GUTS Yearly Total Debt VS Total AssetsGUTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • GUTS has an Altman-Z score of -8.12. This is a bad value and indicates that GUTS is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -8.12, GUTS is doing worse than 75.66% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.12
ROIC/WACCN/A
WACC10.64%
GUTS Yearly LT Debt VS Equity VS FCFGUTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

  • A Current Ratio of 4.27 indicates that GUTS has no problem at all paying its short term obligations.
  • GUTS has a better Current ratio (4.27) than 68.78% of its industry peers.
  • GUTS has a Quick Ratio of 4.27. This indicates that GUTS is financially healthy and has no problem in meeting its short term obligations.
  • GUTS has a better Quick ratio (4.27) than 73.55% of its industry peers.
Industry RankSector Rank
Current Ratio 4.27
Quick Ratio 4.27
GUTS Yearly Current Assets VS Current LiabilitesGUTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. GUTS Growth Analysis

3.1 Past

  • GUTS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.88%.
EPS 1Y (TTM)-5.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.66% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y56.56%
EPS Next 2Y26.19%
EPS Next 3Y20.8%
EPS Next 5Y18.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GUTS Yearly Revenue VS EstimatesGUTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2027 2028 2029 2030 100M 200M 300M 400M
GUTS Yearly EPS VS EstimatesGUTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

1

4. GUTS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GUTS. In the last year negative earnings were reported.
  • Also next year GUTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GUTS Price Earnings VS Forward Price EarningsGUTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GUTS Per share dataGUTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

  • GUTS's earnings are expected to grow with 20.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.19%
EPS Next 3Y20.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GUTS Dividend Analysis

5.1 Amount

  • GUTS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GUTS Fundamentals: All Metrics, Ratios and Statistics

FRACTYL HEALTH INC

NASDAQ:GUTS (3/26/2026, 8:26:43 PM)

After market: 0.4703 0 (-0.61%)

0.4732

-0.03 (-5.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-24
Earnings (Next)05-12
Inst Owners75.4%
Inst Owner Change15.56%
Ins Owners1.36%
Ins Owner Change0.09%
Market Cap72.57M
Revenue(TTM)N/A
Net Income(TTM)-122.20M
Analysts83.64
Price Target5.34 (1028.49%)
Short Float %8.89%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-87.75%
Min EPS beat(2)-120.28%
Max EPS beat(2)-55.23%
EPS beat(4)0
Avg EPS beat(4)-48.37%
Min EPS beat(4)-120.28%
Max EPS beat(4)-0.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-29.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.14%
EPS NY rev (1m)0%
EPS NY rev (3m)1.23%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 24191.56
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.62
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -106.94%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 100%
FCFM N/A
ROA(3y)-97.75%
ROA(5y)-92.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 73.35%
Cap/Sales 26233.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.27
Quick Ratio 4.27
Altman-Z -8.12
F-Score2
WACC10.64%
ROIC/WACCN/A
Cap/Depr(3y)132.87%
Cap/Depr(5y)81.29%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.85%
EPS Next Y56.56%
EPS Next 2Y26.19%
EPS Next 3Y20.8%
EPS Next 5Y18.66%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-10.49%
EBIT Next 3Y-3.57%
EBIT Next 5Y23.95%
FCF growth 1Y-93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.21%
OCF growth 3YN/A
OCF growth 5YN/A

FRACTYL HEALTH INC / GUTS Fundamental Analysis FAQ

What is the fundamental rating for GUTS stock?

ChartMill assigns a fundamental rating of 2 / 10 to GUTS.


What is the valuation status for GUTS stock?

ChartMill assigns a valuation rating of 1 / 10 to FRACTYL HEALTH INC (GUTS). This can be considered as Overvalued.


What is the profitability of GUTS stock?

FRACTYL HEALTH INC (GUTS) has a profitability rating of 1 / 10.


What is the financial health of FRACTYL HEALTH INC (GUTS) stock?

The financial health rating of FRACTYL HEALTH INC (GUTS) is 3 / 10.


What is the earnings growth outlook for FRACTYL HEALTH INC?

The Earnings per Share (EPS) of FRACTYL HEALTH INC (GUTS) is expected to grow by 56.56% in the next year.